Medical Director, International Medical Lead - Neurology

Contenuto del lavoro

Director, Global Medical Affairs, Neurology International Lead

Position Summary

As an integral member of the Global Medical Affairs team, the Neurology International Lead will develop the regional medical-scientific Medical Affairs’ strategies in close alignment with the global strategic objectives.

The Neurology International Lead will contribute to global strategic planning and provide medical leadership in his/her Therapeutic Area (TA) for the International Region, in close collaboration with other functions (Commercial, Clinical Development, Regulatory Affairs, etc). Responsible for providing strong scientific and medical expertise with an in-depth understanding of the TA landscape. Support the Alexion Global Medical Affairs mission to maximize patient outcomes. Leads, from a scientific/clinical standpoint, the country medical teams within the International Regional with a primary focus on Europe.

The Neurology International Lead will lead an exceptional medical affairs organization with focus in Europe that appropriately supports the needs of health care providers, patients, and HTA’s with respect to andexanet alfa. S/he will ensure Alexion has a scientifically robust and meaningful presence at medical-scientific presentations and conferences; and has a clear strategy for thought leader engagement, insights gathering, evidence generation, and life cycle management in the region; s/he will also ensure compliance of Medical Affairs activities with Alexion’s policies and procedures, local regulatory and legal requirements.

Job Duties & Responsibilities

• Within her/his International Medical Affairs responsibilities, will partner with the European Medical Affairs teams, and serve as key member of Global Medical Affairs Leadership Team.
• As part of the Global Medical Affairs Team, provide expertise for the development of a global strategic and global/regional tactical medical plans with focus in the EU, to deliver in alignment with the brands strategic objectives; including but not limited to scientific publications, scientific congresses, medical education opportunities, medical scientific liaison engagements, and patient advocacy engagements (in collaboration with Medical Communication and Patient Insights).
• Support the implementation of the strategic and tactical Medical Affairs plans in close collaboration with cross-functional team members.
• Provides leadership to establish and execute EU medical plan for andexanet alfa and ensure all EU medical affairs activities are aligned with: global strategy, regional and local needs, and cross functionally (GMA, International Leadership team, EU Commercial, EU Market Access).
• Define and articulate European evidence generation and lifecycle management imperatives and integrate with the global evidence generation plan.
• Provide expertise as appropriate to Global Medical Affairs for the development of European Medical strategies and support the execution of European Medical deliverables.
• Build partnerships and relationships with the scientific and medical community at the regional European level and the local country level.
• Represent Alexion externally in scientific presentations, conferences and interactions with industry groups related to the TA.
• In collaboration with Medical Communication, oversee the interpretation, publication/public disclosure, and accurate use of medical-scientific data across Europe and advise on the development of scientific content for medical communication and scientific education initiatives.
• Ensure the scientific integrity of Alexion sponsored and externally sponsored research, disease and product information, and relationships with healthcare providers and patient advocacy groups.
• Provide medical oversight for European medical education programs, grants, sponsorships, externally sponsored research and medical information services.
• Develop and maintain collaborative and effective relationships with thought leaders and interact with key members of the medical and scientific community.
• Drive preparation of and actively participate in global, European and selected local country scientific conferences and patient advocacy meetings.
• In close alignment with Global Clinical Development and Global Medical Affairs, develop collaborations with external research groups.
• Provide timely and well-informed guidance to broader activities, including but not limited to health technology appraisals; business development opportunities.
• Ensure compliance of all European Medical Affairs activities with Portola policies and procedures, as well as all local regulatory and legal requirements.
• Contribute to a high-performance culture by fostering patient centricity innovation, integrity customer focus, empowering the teams, personal accountability and commitment for results.
  
  Essential Qualifications
• Demonstrable leadership experience in Medical Affairs in a pharmaceutical/biotech organization, having led an EU-5 country affiliate Medical Affairs team and/or a regional/global Medical Affairs team, ideally encompassing exposure to entrepreneurial and patient-focused cultures.
• Track record of having played a central role (from a medical perspective) of product launches on a multi-country level.
• Experience with the commercialization of innovative and/or rare disease therapies.
• Solid understanding of the European regulations that govern Medical Affairs activities as well as knowledge of common local medical practices.
• Working knowledge of all stages of clinical development, regulatory requirements, epidemiology, biostatistics, and experience in pharmacoeconomic, ideally across multiple EU countries.
• Strong track record of building effective, ethical, compliant, and professional relationships with healthcare professionals, medical-scientific associations, by engaging thought leaders, enhancing brand awareness, and effectively navigating community politics.
• Demonstrated ability to achieve and maintain scientific credibility, objectivity, and transparency, while being commercially supportive.
• Proven track record of effectively communicating scientific results and responding to data queries from customers and/or consultants.
• Demonstrated ability to work effectively in a collaborative matrix environment where results are achieved through solid scientific influence and the incorporation of multiple points of view.
• Excellent organizational skills, agility, ability to excel in an extremely fast-paced environment with changing priorities, passion and resilience needed to drive initiatives.
• Capability of working autonomously or as part of a team with a ‘sleeves rolled up’ approach and in a collaborative manner; not an empire builder.
• Learning agile, able to tackle new and ambiguous situations leveraging accumulated knowledge and diverse skill sets.
• Motivational, inspirational style with strong influencing and communication skills and innate drive for results.
• A goal-oriented person who both plans for the long-term and executes for the short term.
• An innovative, data-driven person with a “can do” attitude and willingness to do the work.
• High bar personal ethics with a “patients first” value system.
• Excellent written and oral communication skills (in English and at least one other major European language), including strong formal presentation skills in front of internal and external audiences with the ability to “speak up” in meetings with scientific leaders and experts.
• Identifying with and embracing Alexion’s values: patient-focused approach, integrity, innovation, and empowering people

,

Some opportunities happen only once in a lifetime - like a job where you have the extraordinary opportunity to change lives. At Alexion, such opportunities arise through our unwavering mission to serve patients and families affected by rare diseases. These patients are our guiding star, and we act with integrity, urgency, and discipline because we know their lives are at stake.

Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. As a leader in rare diseases for more than 25 years, Alexion has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder (NMOSD). Alexion also has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D) as well as the first and only approved Factor Xa inhibitor reversal agent. In addition, the company is developing several mid-to-late-stage therapies, including a copper-binding agent for Wilson disease, an anti-neonatal Fc receptor (FcRn) antibody for rare Immunoglobulin G (IgG)-mediated diseases and an oral Factor D inhibitor as well as several early-stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third complement inhibitor. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders and cardiology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries. Further information about Alexion can be found at: www.alexion.com.